Yu Fei Huang
Chief Tech/Sci/R&D Officer presso Zhejiang Taimei Medical Technology Co., Ltd.
Profilo
Yu Fei Huang is currently the Chief Technology Officer & Executive Director at Zhejiang Taimei Medical Technology Co., Ltd.
He started this position in 2023.
Prior to his current role, he obtained an undergraduate degree from the University of Science & Technology of China in 2002 and a graduate degree from the same university in 2005.
Posizioni attive di Yu Fei Huang
Società | Posizione | Inizio |
---|---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Chief Tech/Sci/R&D Officer | 28/06/2016 |
Formazione di Yu Fei Huang
University of Science & Technology of China | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Technology Services |
- Borsa valori
- Insiders
- Yu Fei Huang